Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Large-scale testing (Phase 3)Looking for participantsNCT06493552
What this trial is testing

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Who this might be right for
Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 700
Testing effectiveness (Phase 2)Looking for participantsNCT06417190
What this trial is testing

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Who this might be right for
Muscle-Invasive Bladder CarcinomaTumor
Leslie Ballas 20
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableUnknownNCT05097404
What this trial is testing

Clinical Utility of VI-RADS in Diagnosis of MIBC

Who this might be right for
Radical CystectomyMuscle-Invasive Bladder CarcinomaMultiparametric MRI+1 more
Samsung Medical Center 73
Not applicableNot Yet RecruitingNCT06325423
What this trial is testing

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Assiut University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06528483
What this trial is testing

Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerBladder Urothelial CarcinomaBladder Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 63
Testing effectiveness (Phase 2)Looking for participantsNCT06263153
What this trial is testing

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
Yuanquan Yang 24
Post-approval studies (Phase 4)Looking for participantsNCT06215976
What this trial is testing

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Cairo University 78
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Early research (Phase 1)Active Not RecruitingNCT04610671
What this trial is testing

Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Testing effectiveness (Phase 2)Looking for participantsNCT05203913
What this trial is testing

Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32
Testing effectiveness (Phase 2)UnknownNCT06074484
What this trial is testing

RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Testing effectiveness (Phase 2)Study completedNCT02365818
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Who this might be right for
Bladder Cancer
CG Oncology, Inc. 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04506554
What this trial is testing

Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fox Chase Cancer Center 81
Not applicableUnknownNCT04686149
What this trial is testing

A Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Yonsei University 39
Not applicableStudy completedNCT05028660
What this trial is testing

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Elypta 43
Not applicableLooking for participantsNCT04900558
What this trial is testing

Robotic Radical Cystectomy Outcomes

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaOncology+2 more
University of Florence 500
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06257017
What this trial is testing

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Yung NA 20
Load More Results